Back to Search Start Over

Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives

Authors :
Gilles Dolivet
Estelle Festor
Robert-Michel Parache
Christophe Dubessy
Laurent Verneuil
Patrick Erbacher
Jean-Paul Behr
Jean-Louis Merlin
François Guillemin
Département d’Oncologie Médicale [Vandoeuvre Les Nancy]
Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL)
UNICANCER-UNICANCER
Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale [CHRU Nancy]
Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)
Centre Alexis Vautrin (CAV)
IUT Nancy-Brabois [UHP]
Université Henri Poincaré - Nancy 1 (UHP)
Laboratoire de chimie bioorganique (LCB)
Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS)
Source :
Cancer Gene Therapy, Cancer Gene Therapy, Nature Publishing Group, 2001, 8 (3), pp.203-210. ⟨10.1038/sj.cgt.7700289⟩
Publication Year :
2001
Publisher :
Springer Science and Business Media LLC, 2001.

Abstract

International audience; Polyethylenimine (PEI) derivatives are potent polycationic nonviral vectors for gene transfer. The gene transfer efficiency of glucosylated and galactosylated PEI derivatives was optimized using green fluorescent protein gene as reporter gene in FaDu and PANC3 human carcinoma cell lines. Glucosylated or galactosylated PEI derivatives were found to be slightly less cytotoxic than unsubstituted PEI. Gene transfer efficiency was found to be related to DNA/cell number ratio and optimal gene transfer efficiency was achieved at 4 microg DNA/10(5) cells. PEI-DNA complexes were found to enter cells rapidly and were detected into cytoplasmic vesicles 2 hours post-transfection. Green fluorescent protein gene expression was detected 4-6 hours after transfection and reached maximal value 24 hours post-transfection. The results achieved demonstrated that glucosylated PEI yield higher and longer gene transfer efficiency than unsubstituted PEI. Using glucosylated PEI allowed to achieve significant gene transfer in more than 10% of the total cell population for more than 4 days. These data were then applied to p53 gene transfer in PANC3 cells bearing p53 gene deletion and consequently unable to initiate apoptosis. Using glucosylated PEI, p53 gene transfer was successfully achieved with subsequent recovery of p53 mRNA expression and transient P53 protein expression. P53 protein functionality was further demonstrated because transfected cells underwent apoptosis.

Details

ISSN :
14765500 and 09291903
Volume :
8
Database :
OpenAIRE
Journal :
Cancer Gene Therapy
Accession number :
edsair.doi.dedup.....33cd53b4501988aa01ca637f5b0db903
Full Text :
https://doi.org/10.1038/sj.cgt.7700289